1 Min Read
Dec 17 (Reuters) - Epigenomics AG :
* Says first patients enrolled in Epigenomics’ Epi proColon admit study Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.